Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 41 announcements

Share price
₹529.80
Market cap
₹8,433 Cr
Revenue (annual)
₹829.0 Cr
Net profit (annual)
₹163.0 Cr
P/E (TTM)
47.8×Sector 53.1×
Promoter holding
60.92%+0.00% QoQ
FII holding
5.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:59 IST NSE
Financial Results

Thyrocare Technologies Q4 FY26 Results: Net Profit ₹48.7 Cr, Up 125.5% YoY

Thyrocare Technologies Ltd reported revenue from operations of ₹223.9 Cr (+19.6% YoY) and net profit of ₹48.7 Cr (+125.5% YoY) for Q4 FY26.

Key figure
Net profit ₹48.7 Cr · +125.5% YoY
17:58 IST NSE
Financial Results

Thyrocare Technologies Financial Results

Thyrocare Technologies reported FY26 consolidated revenue of ₹829.04 Crore and PAT of ₹162.85 Crore. The Board recommended a final dividend of ₹7.00 per share and approved the appointment of Price Waterhouse LLP as Statutory Auditors. The company also announced a ₹5.50 Crore investment in its wholly-owned subsidiary, Think Health Diagnostics.